Co-Diagnostics CODX
NASDAQ CODX
$0.53 -0.04 (-6.42%)
As of: Oct 23, 2026 · 3:53 PM EDT

Co-Diagnostics (CODX) Gross Margin (2017 - 2026)

Updated

Co-Diagnostics' Gross Margin was 72.73% in Q2 2026, down 7.56 percentage points from 80.29% a year earlier.

Analysis

Co-Diagnostics (CODX) Gross Margin (2017 - 2026) Analysis & Trends

On a trailing twelve-month basis, Co-Diagnostics' Gross Margin was 66.67% through Jun 30, 2026, up 27.07 percentage points year-over-year; for FY2025, it was 64.28%, down 10.20 percentage points from FY2024.

  • Gross Margin shows a five-year change of -13.47 percentage points (FY2020 to FY2025).
  • In earlier years, Gross Margin was 74.48% in FY2024 (+35.92 pp), 38.57% in FY2023 (-45.42 pp), 83.98% in FY2022 (-4.19 pp) and 88.18% in FY2021 (+10.43 pp).
  • Quarterly Gross Margin has moved between -132.09% (Q2 2023) and 92.02% (Q2 2024) over five years.
  • Compared with a year earlier, Gross Margin was higher in three of the last seven quarters, with an average year-over-year change of +1.39 percentage points.
  • The best year-over-year quarter for Gross Margin over five years was Q2 2024 (a gain of 224.11 percentage points); the worst was Q2 2023 (a drop of 213.87 percentage points).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
API Access

Co-Diagnostics Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=CODX&period=max&api_key=YOUR_API_KEY